In a guideline published in the British Medical Journal on March 2, the World Health Organization (WHO) is advising against the use of hydroxychloroquine to prevent infection from the CCP virus, which causes the disease COVID-19. The WHO assembled an international panel of experts—consisting of physicians, scientists, an ethicist, and four patients who recovered from COVID—to review data of six randomized controlled studies involving 6,059 participants who were or were not exposed to an individual with the CCP (Chinese Communist Party) virus. They found that hydroxychloroquine had a “small or no effect” on hospitalizations, deaths, and laboratory-confirmed virus infections, and added that the anti-inflammatory drug may have increased the risk of adverse events. “The panel judged that almost all people would not consider this drug worthwhile,” the authors of the guideline said. In addition, “The panel considers that this drug is no longer a research priority and that resources should rather …